Core Viewpoint - Changshan Pharmaceutical (300255) announced that its controlling shareholder and actual controller, Gao Shuhua, plans to transfer 46 million shares of unrestricted circulating stock, representing 5.0051% of the company's total share capital, to Chongqing Element Private Securities Investment Fund Management Co., Ltd. [1] Summary by Relevant Sections - Share Transfer Details - Gao Shuhua intends to transfer 46 million shares, which will result in Element Fund holding 5.0051% of the company's total shares after the transfer is completed [1]. - Impact on Shareholding Structure - Following the transfer, Element Fund will become a shareholder holding more than 5% of the company, indicating a significant change in the ownership structure [1].
常山药业:控股股东、实际控制人高树华拟协议转让5.0051%公司股份